Detection and localization of surgically resectable cancers with a multi-analyte blood test
Earlier detection is key to reducing cancer deaths. Here, we describe a blood test that can
detect eight common cancer types through assessment of the levels of circulating proteins and …
detect eight common cancer types through assessment of the levels of circulating proteins and …
[HTML][HTML] Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
…, B Lee, J Ptak, N Silliman, L Dobbyn… - … England Journal of …, 2022 - Mass Medical Soc
Background The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
The earlier diagnosis of cancer is one of the keys to reducing cancer deaths in the future. Here
we describe our efforts to develop a noninvasive blood test for the detection of pancreatic …
we describe our efforts to develop a noninvasive blood test for the detection of pancreatic …
A combination of molecular markers and clinical features improve the classification of pancreatic cysts
Background & Aims The management of pancreatic cysts poses challenges to both patients
and their physicians. We investigated whether a combination of molecular markers and …
and their physicians. We investigated whether a combination of molecular markers and …
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
…, KW McMahon, I Kinde, L Dobbyn… - Proceedings of the …, 2015 - National Acad Sciences
Cell-free DNA shed by cancer cells has been shown to be a rich source of putative tumor-specific
biomarkers. Because cell-free DNA from brain and spinal cord tumors cannot usually …
biomarkers. Because cell-free DNA from brain and spinal cord tumors cannot usually …
Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer
…, J Ptak, MJ Schaeffer, N Silliman, L Dobbyn, L Li… - JAMA …, 2019 - jamanetwork.com
Importance Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence
by eradicating minimal residual disease. However, which patients remain at high risk of …
by eradicating minimal residual disease. However, which patients remain at high risk of …
[HTML][HTML] Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease
…, L Gurski, SE McCarthy, HM Kang, L Dobbyn… - Nature …, 2022 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters human host cells
via angiotensin-converting enzyme 2 (ACE2) and causes coronavirus disease 2019 (COVID-…
via angiotensin-converting enzyme 2 (ACE2) and causes coronavirus disease 2019 (COVID-…
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
…, CS Karapetis, T Price, MJ Schaefer, J Ptak, L Dobbyn… - Gut, 2019 - gut.bmj.com
Objective For patients with locally advanced rectal cancer (LARC), adjuvant chemotherapy
selection following surgery remains a major clinical dilemma. Here, we investigated the …
selection following surgery remains a major clinical dilemma. Here, we investigated the …
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
…, M Popoli, J Schaefer, N Silliman, L Dobbyn… - Science translational …, 2018 - science.org
… study; BV, JP, JS, NS, L. Dobbyn, and MP performed the sample preparation and massively
… ; LL, BA, L. Danilova, and CT developed the algorithm for statistical analysis; RHH, I.-MS, T.-…
… ; LL, BA, L. Danilova, and CT developed the algorithm for statistical analysis; RHH, I.-MS, T.-…
Prognostic potential of circulating tumor DNA measurement in postoperative surveillance of nonmetastatic colorectal cancer
…, M Popoli, J Schaefer, N Silliman, L Dobbyn… - JAMA …, 2019 - jamanetwork.com
… In comparison to ctDNA level, the CEA level was positive (>5 μg/L) in 5 (63%; 95% CI, 24%-91%)
of the 8 patients who had a recurrence and none (0%; 95% CI, 0%-11%) of the 32 …
of the 8 patients who had a recurrence and none (0%; 95% CI, 0%-11%) of the 32 …